Unusual or Nonreportable Results from Prenatal cfDNA-Sequencing Suggestive for an Occult Maternal Cancer By Ogkologos - December 13, 2024 533 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the IDENTIFY study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Announces 2026 Society Award Recipients Honouring Excellence in Cancer Research, Care and Leadership Adjuvant Olaparib Continues to Improve Multiple Outcomes in Patients with Germline BRCA1/2-associated High-Risk HER2-negative EBC EMA Recommends Refusing the Marketing Authorisation for Copper (64Cu) Oxodotreotide MOST POPULAR EMA Recommends Extension of Therapeutic Indications for Tremelimumab July 20, 2023 Better EFS Outcomes with Perioperative Durvalumab Plus FLOT Than with Placebo... June 10, 2025 FDA Approves Belzutifan for Advanced Renal Cell Carcinoma January 19, 2024 EMA Recommends Extending Indications for Trastuzumab Deruxtecan to Include Treatment of... October 12, 2023 Load more HOT NEWS Telisotuzumab Vedotin Associated with Durable Responses in c-Met Protein–Overexpressing Non-Squamous EGFR-wild-type... How repurposing a drug in a COVID-19 trial could benefit people... Overall Breast Cancer Incidence Down Since 1999, Rates Increase for Women... Treatment with Nivolumab and Low-Dose Ipilimumab is Effective and Tolerable in...
